Real-time enrollment status for this chronic lymphocytic leukemia clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 2:01 PM UTC
| NCT Number | NCT03331198 |
| Recruiting Status | Recruiting |
| Condition | Chronic Lymphocytic Leukemia |
| Phase | Clinical Trial |
| Target Enrollment | 320 participants |
| Active Locations | 83 sites in the US |
| Sponsor | Juno Therapeutics, a Subsidiary of Celgene |
| Last Updated on CT.gov | February 12, 2026 (2 weeks ago) |
As of March 2, 2026: Clinical trial NCT03331198 is currently recruiting participants. This clinical trial study for chronic lymphocytic leukemia is actively seeking new participants at 83 locations across the United States. The study is sponsored by Juno Therapeutics, a Subsidiary of Celgene. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03331198 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 83 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03331198 was last updated 2 weeks ago (February 12, 2026). HelloStudys verifies this status automatically.